[ad_1]
eBook provides biopharmaceutical decision-makers with the next information to meet the challenges and opportunities that lie ahead
RALEIGH, N.C. – November 27, 2019 – Syneos Health ™ (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today released a trend forecast outlining the critical changes and underlying dynamics that will drive decision-making in the biopharmaceutical sector. 2019. Health trend tenlooks beyond numbers and statistics, transforming industry uncertainties into informative trends, relevant questions, and actionable information.
"In 2019, health market dynamics will require increased agility and responsiveness in biopharmaceutical decision-making," said Syneos Health President and CEO Alistair Macdonald. "The data will not be enough to solve the complex problems of today and tomorrow. Data will need to be synthesized to provide critical information and targeted solutions that take into account the possibilities of science. "
Syneos Health leveraged the knowledge and experience of industry leaders, industry leaders, clinical and business leaders to generate macroeconomic trends and 40 themes for 2019. Key Trends:
- Radical reorganization: Internal change occurs rapidly in 2019. It is motivated by a fundamental economic need to relax the cost structure. More importantly, it is fueled by a new commitment of mixing talent, encouraging collaboration and always innovating from the patient's point of view.
- Evidence in acceleration: Regulators around the world are creating policies and collaborations to test innovative science and technology faster to understand the true impact of treatment and to learn seamlessly around the world.
- Relearning Launch: The need for bold launches is greater than ever; yet we are entering 2019, limited by resources and motivation. As science and the economy become more complex, teams need to prepare markets more comprehensively, redefining metrics and regional relevance.
- Find the right patients: Data takes science. Next year, the most important idea will not be how a drug works, but for whom it works. Systems, media and disrupters are becoming more and more sophisticated in the way they find, engage and support these patients with the best choices and the right experience for them.
- Request for decision insights: Pharmaceutical industry leaders are pbadionate about creating change – and looking for the momentum to make it happen. Look for new calls to create business cases faster, improve the fluidity of institutional data, and integrate behavioral science into everything we do.
- HCP rewired: The provider profession has changed dramatically in 2019. Doctors are finding themselves with less control, bigger financial stakes, and more and more important mental health challenges – all in a climate with more and more people. information at your fingertips and less time than ever.
- Relieve the burden: The weight of work is accumulating on our most critical stakeholders. Old and new players are adopting strategies and services that reduce friction, complexity and inconvenience in the clinical and commercial landscape.
- Value puzzle: Debates over value may be old, but innovation, politics and data have revitalized them for 2019. People, payers and advocates want to know: is it worth it? And who should pay?
- System of oneCare is increasingly occurring where health is present – in the clinic, at home, in local pharmacies and even on the phone. In 2019, the patient's experience – from day-to-day health to inclusion in clinical trials – will be more transitory, opportunistic and data-centric.
- The new top talent: The mbadive evolution of customer expectations and the reality of healthcare is fueling the demand for talent ready to excel in this new era. Companies reorganize, rethink and recruit for 2019.
EBook author, Leigh Householder, Executive Vice President for Insights and Innovations at Syneos Health, commented, "We are entering this new year inspired by the power of science, the persistence of patients and the success of survivors . These trends, as well as the important conversation they foster, will drive biopharmaceutical leaders to innovate in the way they test and market treatments for patients. "
Syneos Health is publishing for the eighth time a healthcare trend forecast that collects and badyzes indices, examples and actionable information collected by observers of global trends in society. Building on the company's successful communications and business trends predictions published in previous years, this year's edition is the first of its kind – offering end-to-end insights for the company. 39, biopharmaceutical industry.
Trends Implications – Connect with us to learn more
- Download the Health EBook Trends Ten 2019 read the 10 macro trends and 40 themes for 2019. In addition, access 10 worksheets to help evolve or transform planning for 2019.
- Subscribe to our podcast for more complete coverage of the Health Trends 10 and implications for biopharmaceutical companies in 2019.
- Follow Syneos Health on LinkedIn, Twitter, Facebook, where our leaders will share their views on these trends.
About Syneos Health
Syneos Health (Nasdaq: SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and a Contract Sales Organization (CCO), is specifically designed to accelerate customer performance to meet the realities of the modern marketplace. Created as a result of the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 23,000 clinical and business minds to support clients in more than 110 countries. Together, we share our ideas, use the latest technologies and apply advanced business practices to accelerate our clients' delivery of important patient treatments. To find out more about our situation to shorten the distance between the laboratory and life® visit syneoshealth.com.
contacts
Investor Relations:
Ronnie Speight
Senior Vice President, Investor Relations
+1 919 745 2745
[email protected]
Press / Media:
Danielle DeForge
Executive Director, External Communications
+1 202 210 5992
[email protected]
[ad_2]
Source link
